198 related articles for article (PubMed ID: 19741728)
1. Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution.
Santos FP; Faderl S; Garcia-Manero G; Koller C; Beran M; O'Brien S; Pierce S; Freireich EJ; Huang X; Borthakur G; Bueso-Ramos C; de Lima M; Keating M; Cortes J; Kantarjian H; Ravandi F
Leukemia; 2009 Dec; 23(12):2275-80. PubMed ID: 19741728
[TBL] [Abstract][Full Text] [Related]
2. Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.
Barnard DR; Alonzo TA; Gerbing RB; Lange B; Woods WG;
Pediatr Blood Cancer; 2007 Jul; 49(1):17-22. PubMed ID: 16856158
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: a retrospective study of 54 cases.
Colita A; Belhabri A; Chelghoum Y; Charrin C; Fiere D; Thomas X
Ann Oncol; 2001 Apr; 12(4):451-5. PubMed ID: 11398875
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients.
Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM
Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848
[TBL] [Abstract][Full Text] [Related]
5. An analysis of 97 previously diagnosed de novo adult acute erythroid leukemia patients following the 2016 revision to World Health Organization classification.
Qiu S; Jiang E; Wei H; Lin D; Zhang G; Wei S; Zhou C; Liu K; Wang Y; Liu B; Liu Y; Gong B; Gong X; Feng S; Mi Y; Han M; Wang J
BMC Cancer; 2017 Aug; 17(1):534. PubMed ID: 28793875
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
[TBL] [Abstract][Full Text] [Related]
7. Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB study.
Davey FR; Abraham N; Brunetto VL; MacCallum JM; Nelson DA; Ball ED; Griffin JD; Baer MR; Wurster-Hill D; Mayer RJ
Am J Hematol; 1995 May; 49(1):29-38. PubMed ID: 7741135
[TBL] [Abstract][Full Text] [Related]
8. Shifting of erythroleukemia to myelodysplastic syndrome according to the revised WHO classification: Biologic and cytogenetic features of shifted erythroleukemia.
Ryu S; Park HS; Kim SM; Im K; Kim JA; Hwang SM; Yoon SS; Lee DS
Leuk Res; 2018 Jul; 70():13-19. PubMed ID: 29729583
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of clinical characteristics and prognosis of 13 cases of acute erythroleukemia].
Guo YL; Zhou MH; Cao TT; Dou LP; Lu XL; Zhang QF; Yao ZL; Wang LL; Yu L; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1142-7. PubMed ID: 24156422
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype.
Mi Y; Xue Y; Yu W; Liu S; Zhao Y; Meng Q; Bian S; Wang J
Leuk Lymphoma; 2008 Mar; 49(3):524-30. PubMed ID: 18297530
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher-risk myelodysplastic syndromes: a prospective multicenter single-arm trial.
Zhou X; Mei C; Zhang J; Lu Y; Lan J; Lin S; Zhang Y; Kuang Y; Ren Y; Ma L; Wei J; Ye L; Xu W; Li K; Lu C; Jin J; Tong H
Hematol Oncol; 2020 Oct; 38(4):531-540. PubMed ID: 32469434
[TBL] [Abstract][Full Text] [Related]
12. Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as "AML not otherwise specified" (AML-NOS) or "AML with myelodysplasia-related changes" (AML-MRC).
Miesner M; Haferlach C; Bacher U; Weiss T; Macijewski K; Kohlmann A; Klein HU; Dugas M; Kern W; Schnittger S; Haferlach T
Blood; 2010 Oct; 116(15):2742-51. PubMed ID: 20581309
[TBL] [Abstract][Full Text] [Related]
13. Clinical, morphologic, and cytogenetic characteristics of 26 patients with acute erythroblastic leukemia.
Olopade OI; Thangavelu M; Larson RA; Mick R; Kowal-Vern A; Schumacher HR; Le Beau MM; Vardiman JW; Rowley JD
Blood; 1992 Dec; 80(11):2873-82. PubMed ID: 1450412
[TBL] [Abstract][Full Text] [Related]
14. Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
Almeida AM; Prebet T; Itzykson R; Ramos F; Al-Ali H; Shammo J; Pinto R; Maurillo L; Wetzel J; Musto P; Van De Loosdrecht AA; Costa MJ; Esteves S; Burgstaller S; Stauder R; Autzinger EM; Lang A; Krippl P; Geissler D; Falantes JF; Pedro C; Bargay J; Deben G; Garrido A; Bonanad S; Diez-Campelo M; Thepot S; Ades L; Sperr WR; Valent P; Fenaux P; Sekeres MA; Greil R; Pleyer L
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28420120
[TBL] [Abstract][Full Text] [Related]
15. The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease.
Goldberg SL; Noel P; Klumpp TR; Dewald GW
Am J Clin Oncol; 1998 Feb; 21(1):42-7. PubMed ID: 9499256
[TBL] [Abstract][Full Text] [Related]
16. Acute erythroid leukemia (M6): outcome of bone marrow transplantation.
Killick S; Matutes E; Powles RL; Min T; Treleaven JG; Rege KP; Atra A; Catovsky D
Leuk Lymphoma; 1999 Sep; 35(1-2):99-107. PubMed ID: 10512167
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome.
Estey EH; Thall PF; Pierce S; Cortes J; Beran M; Kantarjian H; Keating MJ; Andreeff M; Freireich E
Blood; 1999 Apr; 93(8):2478-84. PubMed ID: 10194425
[TBL] [Abstract][Full Text] [Related]
18. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
Tavernier E; Le QH; Elhamri M; Thomas X
Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972
[TBL] [Abstract][Full Text] [Related]
19. Derivative (1;7)(q10;p10) in a patient with de novo acute erythroblastic leukemia (AML-M6).
Obara N; Shinagawa A; Komatsu T; Abe T; Ninomiya H
Cancer Genet Cytogenet; 1999 Nov; 115(1):62-4. PubMed ID: 10565302
[TBL] [Abstract][Full Text] [Related]
20. [Therapy-related acute myelogenous leukemia (AML-M6) with add(11) (q23) and del(20) (q11.2) developing via myelodysplastic syndrome after chemotherapy for malignant lymphoma].
Kawakami K; Watanabe Y; Kadowaki S
Rinsho Ketsueki; 2003 Mar; 44(3):168-73. PubMed ID: 12722343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
